Evidence map›Paper›PMID 35198895›Full record

ArticleiScience2022

Enzymatic activity of glycosyltransferase GLT8D1 promotes human glioblastoma cell migration.

Elena I Ilina, Camille Cialini, Dietlind L Gerloff, Maitane Duarte Garcia-Escudero, Céline Jeanty, Marie-Laëtitia Thézénas, Antoine Lesur, Vincent Puard, François Bernardin, Alina Moter and 8 more

Abstract read
In one paragraph

Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Elena I IlinaDepartment of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Camille CialiniDepartment of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Dietlind L GerloffFoundation for Applied Molecular Evolution (FfAME), Alachua, FL 32615, USA.
Maitane Duarte Garcia-EscuderoDepartment of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Céline JeantyQuantitative Biology Unit, Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Marie-Laëtitia ThézénasQuantitative Biology Unit, Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Antoine LesurQuantitative Biology Unit, Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Vincent PuardQuantitative Biology Unit, Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
François BernardinQuantitative Biology Unit, Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Alina MoterDepartment of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Anne SchusterDepartment of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Monika DieterleDepartment of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Anna GolebiewskaDepartment of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Jean-Jacques GérardyLuxembourg Centre of Neuropathology (LCNP), 1526 Luxembourg, Luxembourg.
Gunnar DittmarQuantitative Biology Unit, Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Simone P NiclouDepartment of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Tanja MüllerDepartment of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.
Michel MittelbronnDepartment of Cancer Research (DoCR), Luxembourg Institute of Health (LIH), 1526 Luxembourg, Luxembourg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GBM) is the most aggressive primary brain tumor characterized by infiltrative growth of malignant glioma cells into the surrounding brain parenchyma. In this study, our analysis of GBM patient cohorts revealed a significantly higher expression of

Indexed as

BiochemistryCancerCell biologyGlycobiology

Identifiers

PMID35198895
PMCPMC8850796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.